PT Kimia Farma (Persero) Tbk - D3 Analyst, Supervisor Analytical Development Kimia Farma April 2020

Advertisements

PT Kimia Farma (Persero) Tbk / kimiafarma.co.id

PT Kimia Farma (Persero) Tbk - Kimia Farma is a well-established public-listed company in Indonesia that deals with the integrated pharmaceutical industry. Its business includes manufacturing, pharmaceutical trade and distribution, retail pharmacy, health clinic, laboratories, and optical clinics. PT Kimia Farma (Persero) Tbk is a state-owned company which is majority-owned by the Government of Indonesia. Kimia Farma is listed on the Indonesia Stock Exchange (IDX) under reference code KAEF. At present, Kimia Farma is 90.025% owned by the Government of Indonesia which represented by the Minister of State-Owned Enterprises (SOE). Other 0.127% by management/employee and 9.848% by public.

Based in Jakarta, Kimia Farma now has 7 production facilities; Plant Jakarta, Plant Bandung, Plant Semarang, Plant Watudakon, Plant Garam Farmasi, Plant Medan, and lant Rapid Test. Kimia Farma also supported by 1 research and development office at Bandung and 1 central logistic unit Jakarta. Kimia Farma also supported 6 directly-owned subsidiaries and affiliated companies, namely PT Kimia Farma Trading & Distribution, PT Kimia Farma Apotek, PT Sinkona Indonesia Lestari, PT Kimia Farma Diagnostik, PT Kimia Farma Sungwun Pharmacopia, and PT Asuransi InHealth Indonesia. As of the end of September 2018, Kimia Farma has 1,135 pharmacies, 530 health clinics, 55 clinical laboratories, and 10 optics throughout Indonesia.

In terms of financial performance, Kimia Farma is running well in the third quarter of 2018 (3Q18, ended on 30 September 2018). According to information found in PT Kimia Farma (Persero) Tbk 2018 Third Quarter Report as quoted by JobsCDC.com, Kimia Farma booked a total net revenue of Rp5.31 trillion (unaudited) as at the end of September 2018. This reflected a 23.37% increase from Rp4.30 trillion (unaudited)  in the same period in 2017. Kima Farma's total profit of Rp483.29 billion in the third quarter of 2018 or 45.31% growth YOY as compared with Rp332.60 billion in the third quarter of 2017.

To support the business expansion and its organic growth, PT Kimia Farma (Persero) Tbk invites qualified candidates to fulfill the position as follows

Analis Bagian Teknis Lab BA / BE

Requirements

• Minimum Associate Degree (D3) Chemical Analyst, Pharmaceutical Analyst.
• Skilled in operating spectrophotometer or HPLC.
• The candidates with prior experience in Quality Control Pharmaceutical Industry or Testing Lab.
• Skilled in operating Microsoft Office.

Supervisor Analytical Development Bagian Teknis Lab BA / BE

Requirements

• Minimum Associate Degree (D3) Chemical Analyst, Pharmaceutical Analyst.
• Minimum 2 years of experience in developing analyst methods in the testing lab industry.
• Minimum 2 years of experience in using HPLC/LCMS-MS.
• Possess certification in analyst.
• Skilled in operating Microsoft Office.

For further information, please refer official source from PT Kimia Farma (Persero) Tbk on following link below. If you match the profile and are interested, please apply in confidence by filling an online application form at  bit.ly/hiring-kimiafarma. Closing date 28 April 2020. All applications are appreciated and will be treated confidentially. Only qualified, short-listed applicants will be invited for furthers process. (JobsCDC.com / Source)

Notes :

JobsCDC.com now available on android device. Download now on Google Play here. Please be aware of recruitment fraud. The entire stage of this selection process is free of charge. PT Kimia Farma (Persero) Tbk - D3 Analyst, Supervisor Analytical Development Kimia Farma April 2020 will never ask for fees or upfront payments for any purposes during the recruitment process such as transportation and accommodation.

Advertisements

Related Jobs :